Kerry Wentworth, Chief Regulatory Officer at Flexion Therapeutics Inc (FLXN), sold 13,658 shares at $11.13 ($152K) on 2021-01-05, disclosed to the SEC on 2021-01-07.
Open-market sale of $152k FLXN by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.13 | 6,829 | $76K | 50.0% |
| 2 | $11.13 | 6,829 | $76K | 50.0% |
| Total | $11.13 avg | 13,658 | $152K | 100% |
| Filing → |
| NUVB | SELL | 2026-04-08 | $904K | — | Filing → |
| NUVB | BUY | 2025-06-18 | $90K | — | Filing → |
| FLXN | SELL | 2021-07-20 | $25K | — | Filing → |